Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2017-10-18
2019-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents
NCT00831883
HIV Prevention Program for Patients Receiving Care at a Sexually Transmitted Diseases Clinic
NCT00183573
Share Safer Sex Counseling Program for Changing Sexual Risk Behaviors in Mexican Female Sex Workers
NCT00338845
HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment
NCT01383837
Prevention of HIV and STDs in Drug Using Women
NCT01235091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Brief Intervention (BI) with Technology Extender
Participants assigned to BI condition will receive a face to face session lasting 45-60 minutes delivered by a health coach. Following the session, participants will be given access to a study website and receive texts-of-the day on study topics.
Brief Intervention (BI) with Technology Extender
One, 45-60 minute BI, followed by three months of access to technology extenders
Brochure
Participants assigned to the Brochure condition will receive materials prepared by the Centers for Disease Control and Prevention on the study topics.
Brochure
Brochures provided one time
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brief Intervention (BI) with Technology Extender
One, 45-60 minute BI, followed by three months of access to technology extenders
Brochure
Brochures provided one time
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-29 years
* Meeting NIAAA definition of "at-risk" drinking (\>3 drinks on any day in the last 3 months18 and/or \>7 drinks per week)
* Sexual risk behavior (i.e., last 3 months: vaginal/anal intercourse with \>1 partner; vaginal/anal intercourse with a partner who has other partners; inconsistent condom use; new relationship (under 3 months))
* English speaking
* Absence of acute intoxication, depression, or suicidal ideation
* No plans for relocation
Exclusion Criteria
* Under 18 years old or older than 29 years old
* Non-English speaking
* Suicidal Ideation
* Relocating
* Clinic provider advising against recruitment in the study
* Unwilling or unable to provide consent
18 Years
29 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Planned Parenthood of Southern New England
OTHER
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
The Miriam Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael P. Carey
Professor and Director, Centers for Behavioral and Preventive Medicine, The Miriam Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael P Carey, PhD
Role: PRINCIPAL_INVESTIGATOR
The Miriam Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Planned Parenthood of Southern New England
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
775844-4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.